10 reports

  • 7.7. ERAVACYCLINE: CURRENT STATUS AND KEY DEVELOPMENTS
  • DRUG PROFILE: DELAFLOXACIN
  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • 9.4.2 Cempra Pharmaceuticals
  • KEY LATE-STAGE PIPELINE AGENTS FOR MRSA, 2015
  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • 4.4.2 Cempra Pharmaceuticals
  • COMPANIES WITH PROMISING PIPELINE CANDIDATES FOR MRSA IN THE 7MM, 2015
  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • KEY LATE-STAGE PIPELINE AGENTS FOR MRSA, 2015
  • OTHER PROMISING PIPELINE PRODUCTS FOR MRSA, 2015

KYORIN PHARMACEUTICAL (2015).

  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • KEY LATE-STAGE PIPELINE AGENTS FOR MRSA, 2015
  • OTHER PROMISING PIPELINE PRODUCTS FOR MRSA, 2015

KYORIN PHARMACEUTICAL (2015).

  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • KEY LATE-STAGE PIPELINE AGENTS FOR MRSA, 2015
  • OTHER PROMISING PIPELINE PRODUCTS FOR MRSA, 2015

KYORIN PHARMACEUTICAL (2015).

  • Anti-Infective
  • Antibiotic Resistance
  • Pharmaceutical
  • Therapy
  • Melinta Therapeutics, Inc.
  • Rib-X Pharma Withdraws IPO
  • Melinta Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details
  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Melinta Therapeutics, Inc.
  • Melinta Therapeutics, Inc - Pharmaceutical Pipeline Products Data
  • Melinta Therapeutics, Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
  • Anti-Infective
  • Pharmaceutical
  • United States
  • Company
  • Melinta Therapeutics, Inc.
  • Other Developmental Activities
  • Melinta Therapeutics, Inc, Key Facts

Dec ##, 2011 Rib-X Pharmaceuticals, Inc.

  • Anti-Infective
  • Pharmaceutical
  • United States
  • Product Initiative
  • Melinta Therapeutics, Inc.
  • TOP DEALS IN (2012 -YTD2016)
  • PARTNERSHIP - DEAL REPORTS
  • Healthcare
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Melinta Therapeutics, Inc.